<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36012480</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>16</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Role of Bioenergetics in Neurodegeneration.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9212</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms23169212</ELocationID><Abstract><AbstractText>Bioenergetic and mitochondrial dysfunction are common hallmarks of neurodegenerative diseases. Decades of research describe how genetic and environmental factors initiate changes in mitochondria and bioenergetics across Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). Mitochondria control many cellular processes, including proteostasis, inflammation, and cell survival/death. These cellular processes and pathologies are common across neurodegenerative diseases. Evidence suggests that mitochondria and bioenergetic disruption may drive pathological changes, placing mitochondria as an upstream causative factor in neurodegenerative disease onset and progression. Here, we discuss evidence of mitochondrial and bioenergetic dysfunction in neurodegenerative diseases and address how mitochondria can drive common pathological features of these diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Strope</LastName><ForeName>Taylor A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>University of Kansas Alzheimer's Disease Center, Kansas City, KS 66205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birky</LastName><ForeName>Cole J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>University of Kansas Alzheimer's Disease Center, Kansas City, KS 66205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Heather M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0003-4563-4544</Identifier><AffiliationInfo><Affiliation>University of Kansas Alzheimer's Disease Center, Kansas City, KS 66205, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS 66160, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 HD090216</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Parkinson&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">bioenergetics</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36012480</ArticleId><ArticleId IdType="pmc">PMC9409169</ArticleId><ArticleId IdType="doi">10.3390/ijms23169212</ArticleId><ArticleId IdType="pii">ijms23169212</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Onyango I.G., Bennett J.P., Stokin G.B. Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases. Neural Regen. Res. 2021;16:1467&#x2013;1482. doi: 10.4103/1673-5374.303007.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.303007</ArticleId><ArticleId IdType="pmc">PMC8323696</ArticleId><ArticleId IdType="pubmed">33433460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Zhao F., Ma X., Perry G., Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer&#x2019;s disease: Recent advances. Mol. Neurodegener. 2020;15:30. doi: 10.1186/s13024-020-00376-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00376-6</ArticleId><ArticleId IdType="pmc">PMC7257174</ArticleId><ArticleId IdType="pubmed">32471464</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow R.H., Burns J.M., Khan S.M. The Alzheimer&#x2019;s disease mitochondrial cascade hypothesis: Progress and perspectives. Biochim. Biophys. Acta. 2014;1842:1219&#x2013;1231. doi: 10.1016/j.bbadis.2013.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.09.010</ArticleId><ArticleId IdType="pmc">PMC3962811</ArticleId><ArticleId IdType="pubmed">24071439</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow R.H., Khan S.M. A &#x201c;mitochondrial cascade hypothesis&#x201d; for sporadic Alzheimer&#x2019;s disease. Med. Hypotheses. 2004;63:8&#x2013;20. doi: 10.1016/j.mehy.2003.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2003.12.045</ArticleId><ArticleId IdType="pubmed">15193340</ArticleId></ArticleIdList></Reference><Reference><Citation>Angelova P.R., Abramov A.Y. Role of mitochondrial ROS in the brain: From physiology to neurodegeneration. FEBS Lett. 2018;592:692&#x2013;702. doi: 10.1002/1873-3468.12964.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12964</ArticleId><ArticleId IdType="pubmed">29292494</ArticleId></ArticleIdList></Reference><Reference><Citation>Perea G., Navarrete M., Araque A. Tripartite synapses: Astrocytes process and control synaptic information. Trends Neurosci. 2009;32:421&#x2013;431. doi: 10.1016/j.tins.2009.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2009.05.001</ArticleId><ArticleId IdType="pubmed">19615761</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose J., Brian C., Pappa A., Panayiotidis M.I., Franco R. Mitochondrial Metabolism in Astrocytes Regulates Brain Bioenergetics, Neurotransmission and Redox Balance. Front. Neurosci. 2020;14:536682. doi: 10.3389/fnins.2020.536682.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.536682</ArticleId><ArticleId IdType="pmc">PMC7674659</ArticleId><ArticleId IdType="pubmed">33224019</ArticleId></ArticleIdList></Reference><Reference><Citation>Misrani A., Tabassum S., Yang L. Mitochondrial Dysfunction and Oxidative Stress in Alzheimer&#x2019;s Disease. Front. Aging Neurosci. 2021;13:617588. doi: 10.3389/fnagi.2021.617588.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.617588</ArticleId><ArticleId IdType="pmc">PMC7930231</ArticleId><ArticleId IdType="pubmed">33679375</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolfi-Donegan D., Braganza A., Shiva S. Mitochondrial electron transport chain: Oxidative phosphorylation, oxidant production, and methods of measurement. Redox Biol. 2020;37:101674. doi: 10.1016/j.redox.2020.101674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101674</ArticleId><ArticleId IdType="pmc">PMC7767752</ArticleId><ArticleId IdType="pubmed">32811789</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X.J., Hu Y.Y., Yang Z.J., Jiang L.P., Shi S.L., Li Y.R., Guo M.Y., Wu H.L., Wan Y.Y. Amyloid beta-42 induces neuronal apoptosis by targeting mitochondria. Mol. Med. Rep. 2017;16:4521&#x2013;4528. doi: 10.3892/mmr.2017.7203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.7203</ArticleId><ArticleId IdType="pmc">PMC5647099</ArticleId><ArticleId IdType="pubmed">28849115</ArticleId></ArticleIdList></Reference><Reference><Citation>Uddin M.S., Kabir M.T., Rahman M.S., Behl T., Jeandet P., Ashraf G.M., Najda A., Bin-Jumah M.N., El-Seedi H.R., Abdel-Daim M.M. Revisiting the Amyloid Cascade Hypothesis: From Anti-Abeta Therapeutics to Auspicious New Ways for Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2020;21:5858. doi: 10.3390/ijms21165858.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21165858</ArticleId><ArticleId IdType="pmc">PMC7461598</ArticleId><ArticleId IdType="pubmed">32824102</ArticleId></ArticleIdList></Reference><Reference><Citation>Troutwine B.R., Hamid L., Lysaker C.R., Strope T.A., Wilkins H.M. Apolipoprotein E and Alzheimer&#x2019;s disease. Acta Pharm. Sin. B. 2022;12:496&#x2013;510. doi: 10.1016/j.apsb.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8897057</ArticleId><ArticleId IdType="pubmed">35256931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong M., Mohammadi-Shemirani P., Perrot N., Nelson W., Morton R., Narula S., Lali R., Khan I., Khan M., Judge C., et al. GWAS and ExWAS of blood mitochondrial DNA copy number identifies 71 loci and highlights a potential causal role in dementia. Elife. 2022;11:e70382. doi: 10.7554/eLife.70382.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.70382</ArticleId><ArticleId IdType="pmc">PMC8865845</ArticleId><ArticleId IdType="pubmed">35023831</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellenguez C., Kucukali F., Jansen I.E., Kleineidam L., Moreno-Grau S., Amin N., Naj A.C., Campos-Martin R., Grenier-Boley B., Andrade V., et al. New insights into the genetic etiology of Alzheimer&#x2019;s disease and related dementias. Nat. Genet. 2022;54:412&#x2013;436. doi: 10.1038/s41588-022-01024-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-022-01024-z</ArticleId><ArticleId IdType="pmc">PMC9005347</ArticleId><ArticleId IdType="pubmed">35379992</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao J., Irwin R.W., Zhao L., Nilsen J., Hamilton R.T., Brinton R.D. Mitochondrial bioenergetic deficit precedes Alzheimer&#x2019;s pathology in female mouse model of Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2009;106:14670&#x2013;14675. doi: 10.1073/pnas.0903563106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0903563106</ArticleId><ArticleId IdType="pmc">PMC2732886</ArticleId><ArticleId IdType="pubmed">19667196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Carl S.M., Swerdlow R.H. Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies. Redox Biol. 2014;2:619&#x2013;631. doi: 10.1016/j.redox.2014.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2014.03.006</ArticleId><ArticleId IdType="pmc">PMC4297942</ArticleId><ArticleId IdType="pubmed">25460729</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva D.F., Selfridge J.E., Lu J., Lezi E., Roy N., Hutfles L., Burns J.M., Michaelis E.K., Yan S., Cardoso S.M., et al. Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines. Hum. Mol. Genet. 2013;22:3931&#x2013;3946. doi: 10.1093/hmg/ddt247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt247</ArticleId><ArticleId IdType="pmc">PMC3888119</ArticleId><ArticleId IdType="pubmed">23740939</ArticleId></ArticleIdList></Reference><Reference><Citation>Gella A., Durany N. Oxidative stress in Alzheimer disease. Cell Adh. Migr. 2009;3:88&#x2013;93. doi: 10.4161/cam.3.1.7402.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cam.3.1.7402</ArticleId><ArticleId IdType="pmc">PMC2675154</ArticleId><ArticleId IdType="pubmed">19372765</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 2002;32:797&#x2013;803. doi: 10.1016/S0891-5849(02)00780-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(02)00780-3</ArticleId><ArticleId IdType="pubmed">11978481</ArticleId></ArticleIdList></Reference><Reference><Citation>Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer&#x2019;s disease. Ann. Neurol. 1994;36:747&#x2013;751. doi: 10.1002/ana.410360510.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410360510</ArticleId><ArticleId IdType="pubmed">7979220</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada E.S., Respondek G., Mussner S., de Andrade A., Hollerhage M., Depienne C., Rastetter A., Tarze A., Friguet B., Salama M., et al. Annonacin, a natural lipophilic mitochondrial complex I inhibitor, increases phosphorylation of tau in the brain of FTDP-17 transgenic mice. Exp. Neurol. 2014;253:113&#x2013;125. doi: 10.1016/j.expneurol.2013.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2013.12.017</ArticleId><ArticleId IdType="pubmed">24389273</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker W.D., Jr., Parks J., Filley C.M., Kleinschmidt-DeMasters B.K. Electron transport chain defects in Alzheimer&#x2019;s disease brain. Neurology. 1994;44:1090&#x2013;1096. doi: 10.1212/WNL.44.6.1090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.6.1090</ArticleId><ArticleId IdType="pubmed">8208407</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosetti F., Brizzi F., Barogi S., Mancuso M., Siciliano G., Tendi E.A., Murri L., Rapoport S.I., Solaini G. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer&#x2019;s disease. Neurobiol. Aging. 2002;23:371&#x2013;376. doi: 10.1016/S0197-4580(01)00314-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(01)00314-1</ArticleId><ArticleId IdType="pubmed">11959398</ArticleId></ArticleIdList></Reference><Reference><Citation>Crugnola V., Lamperti C., Lucchini V., Ronchi D., Peverelli L., Prelle A., Sciacco M., Bordoni A., Fassone E., Fortunato F., et al. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis. Arch. Neurol. 2010;67:849&#x2013;854. doi: 10.1001/archneurol.2010.128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.128</ArticleId><ArticleId IdType="pubmed">20625092</ArticleId></ArticleIdList></Reference><Reference><Citation>Weidling I.W., Wilkins H.M., Koppel S.J., Hutfles L., Wang X., Kalani A., Menta B.W., Ryan B., Perez-Ortiz J., Gamblin T.C., et al. Mitochondrial DNA Manipulations Affect Tau Oligomerization. J. Alzheimer&#x2019;s Dis. 2020;77:149&#x2013;163. doi: 10.3233/JAD-200286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200286</ArticleId><ArticleId IdType="pmc">PMC7962146</ArticleId><ArticleId IdType="pubmed">32804126</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Swerdlow R.H. Amyloid precursor protein processing and bioenergetics. Brain Res. Bull. 2017;133:71&#x2013;79. doi: 10.1016/j.brainresbull.2016.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2016.08.009</ArticleId><ArticleId IdType="pmc">PMC5316384</ArticleId><ArticleId IdType="pubmed">27545490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Troutwine B.R., Menta B.W., Manley S.J., Strope T.A., Lysaker C.R., Swerdlow R.H. Mitochondrial Membrane Potential Influences Amyloid-beta Protein Precursor Localization and Amyloid-beta Secretion. J. Alzheimer&#x2019;s Dis. 2022;85:381&#x2013;394. doi: 10.3233/JAD-215280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-215280</ArticleId><ArticleId IdType="pmc">PMC9212216</ArticleId><ArticleId IdType="pubmed">34806611</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii K., Kitagaki H., Kono M., Mori E. Decreased medial temporal oxygen metabolism in Alzheimer&#x2019;s disease shown by PET. J. Nucl. Med. 1996;37:1159&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">8965188</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohgi H., Yonezawa H., Takahashi S., Sato N., Kato E., Kudo M., Hatano K., Sasaki T. Cerebral blood flow and oxygen metabolism in senile dementia of Alzheimer&#x2019;s type and vascular dementia with deep white matter changes. Neuroradiology. 1998;40:131&#x2013;137. doi: 10.1007/s002340050553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s002340050553</ArticleId><ArticleId IdType="pubmed">9561514</ArticleId></ArticleIdList></Reference><Reference><Citation>Das N., Ren J., Spence J., Chapman S.B. Phosphate Brain Energy Metabolism and Cognition in Alzheimer&#x2019;s Disease: A Spectroscopy Study Using Whole-Brain Volume-Coil (31)Phosphorus Magnetic Resonance Spectroscopy at 7Tesla. Front. Neurosci. 2021;15:641739. doi: 10.3389/fnins.2021.641739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.641739</ArticleId><ArticleId IdType="pmc">PMC8055842</ArticleId><ArticleId IdType="pubmed">33889067</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler N.R. Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: Healthy aging, Alzheimer&#x2019;s disease and Down syndrome. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 1986;10:309&#x2013;321. doi: 10.1016/0278-5846(86)90010-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0278-5846(86)90010-2</ArticleId><ArticleId IdType="pubmed">2948218</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcus C., Mena E., Subramaniam R.M. Brain PET in the diagnosis of Alzheimer&#x2019;s disease. Clin. Nucl. Med. 2014;39:e413&#x2013;e422. doi: 10.1097/RLU.0000000000000547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLU.0000000000000547</ArticleId><ArticleId IdType="pmc">PMC4332800</ArticleId><ArticleId IdType="pubmed">25199063</ArticleId></ArticleIdList></Reference><Reference><Citation>Funayama M., Nishioka K., Li Y., Hattori N. Molecular genetics of Parkinson&#x2019;s disease: Contributions and global trends. J. Hum. Genet. 2022 doi: 10.1038/s10038-022-01058-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s10038-022-01058-5</ArticleId><ArticleId IdType="pubmed">35821405</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Monte D.A., Lavasani M., Manning-Bog A.B. Environmental factors in Parkinson&#x2019;s disease. Neurotoxicology. 2002;23:487&#x2013;502. doi: 10.1016/S0161-813X(02)00099-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0161-813X(02)00099-2</ArticleId><ArticleId IdType="pubmed">12428721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls M.A., Blauwendraat C., Vallerga C.L., Heilbron K., Bandres-Ciga S., Chang D., Tan M., Kia D.A., Noyce A.J., Xue A., et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: A meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091&#x2013;1102. doi: 10.1016/S1474-4422(19)30320-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30320-5</ArticleId><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassarino D.S., Fall C.P., Swerdlow R.H., Smith T.S., Halvorsen E.M., Miller S.W., Parks J.P., Parker W.D., Jr., Bennett J.P., Jr. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson&#x2019;s disease. Biochim. Et Biophys. Acta. 1997;1362:77&#x2013;86. doi: 10.1016/S0925-4439(97)00070-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4439(97)00070-7</ArticleId><ArticleId IdType="pubmed">9434102</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteves A.R., Domingues A.F., Ferreira I.L., Januario C., Swerdlow R.H., Oliveira C.R., Cardoso S.M. Mitochondrial function in Parkinson&#x2019;s disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion. 2008;8:219&#x2013;228. doi: 10.1016/j.mito.2008.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2008.03.004</ArticleId><ArticleId IdType="pubmed">18495557</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteves A.R., Arduino D.M., Swerdlow R.H., Oliveira C.R., Cardoso S.M. Oxidative stress involvement in alpha-synuclein oligomerization in Parkinson&#x2019;s disease cybrids. Antioxid. Redox Signal. 2009;11:439&#x2013;448. doi: 10.1089/ars.2008.2247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2008.2247</ArticleId><ArticleId IdType="pubmed">18717628</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.L., Lin T.Y., Chen P.L., Guo T.N., Huang S.Y., Chen C.H., Lin C.H., Chan C.C. Mitochondrial Function and Parkinson&#x2019;s Disease: From the Perspective of the Electron Transport Chain. Front. Mol. Neurosci. 2021;14:797833. doi: 10.3389/fnmol.2021.797833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2021.797833</ArticleId><ArticleId IdType="pmc">PMC8695848</ArticleId><ArticleId IdType="pubmed">34955747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoglinger G.U., Carrard G., Michel P.P., Medja F., Lombes A., Ruberg M., Friguet B., Hirsch E.C. Dysfunction of mitochondrial complex I and the proteasome: Interactions between two biochemical deficits in a cellular model of Parkinson&#x2019;s disease. J. Neurochem. 2003;86:1297&#x2013;1307. doi: 10.1046/j.1471-4159.2003.01952.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01952.x</ArticleId><ArticleId IdType="pubmed">12911637</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Rodriguez P., Zampese E., Stout K.A., Guzman J.N., Ilijic E., Yang B., Tkatch T., Stavarache M.A., Wokosin D.L., Gao L., et al. Disruption of mitochondrial complex I induces progressive parkinsonism. Nature. 2021;599:650&#x2013;656. doi: 10.1038/s41586-021-04059-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04059-0</ArticleId><ArticleId IdType="pmc">PMC9189968</ArticleId><ArticleId IdType="pubmed">34732887</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetrud J.W., Langston J.W. MPTP-induced parkinsonism as a model for Parkinson&#x2019;s disease. Acta Neurol. Scand. Suppl. 1989;126:35&#x2013;40. doi: 10.1111/j.1600-0404.1989.tb01780.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1989.tb01780.x</ArticleId><ArticleId IdType="pubmed">2694734</ArticleId></ArticleIdList></Reference><Reference><Citation>Javitch J.A., D&#x2019;Amato R.J., Strittmatter S.M., Snyder S.H. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA. 1985;82:2173&#x2013;2177. doi: 10.1073/pnas.82.7.2173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.82.7.2173</ArticleId><ArticleId IdType="pmc">PMC397515</ArticleId><ArticleId IdType="pubmed">3872460</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolato M., Chen K., Shih J.C. Monoamine oxidase inactivation: From pathophysiology to therapeutics. Adv. Drug Deliv. Rev. 2008;60:1527&#x2013;1533. doi: 10.1016/j.addr.2008.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.addr.2008.06.002</ArticleId><ArticleId IdType="pmc">PMC2630537</ArticleId><ArticleId IdType="pubmed">18652859</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao L., Avshalumov M.V., Patel J.C., Lee C.R., Miller E.W., Chang C.J., Rice M.E. Mitochondria are the source of hydrogen peroxide for dynamic brain-cell signaling. J. Neurosci. 2009;29:9002&#x2013;9010. doi: 10.1523/JNEUROSCI.1706-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1706-09.2009</ArticleId><ArticleId IdType="pmc">PMC2892101</ArticleId><ArticleId IdType="pubmed">19605638</ArticleId></ArticleIdList></Reference><Reference><Citation>Heikkila R., Cohen G. Inhibition of biogenic amine uptake by hydrogen peroxide: A mechanism for toxic effects of 6-hydroxydopamine. Science. 1971;172:1257&#x2013;1258. doi: 10.1126/science.172.3989.1257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.172.3989.1257</ArticleId><ArticleId IdType="pubmed">5576164</ArticleId></ArticleIdList></Reference><Reference><Citation>Solesio M.E., Saez-Atienzar S., Jordan J., Galindo M.F. Characterization of mitophagy in the 6-hydoxydopamine Parkinson&#x2019;s disease model. Toxicol. Sci. 2012;129:411&#x2013;420. doi: 10.1093/toxsci/kfs218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfs218</ArticleId><ArticleId IdType="pubmed">22821850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludtmann M.H.R., Angelova P.R., Horrocks M.H., Choi M.L., Rodrigues M., Baev A.Y., Berezhnov A.V., Yao Z., Little D., Banushi B., et al. Alpha-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson&#x2019;s disease. Nat. Commun. 2018;9:2293. doi: 10.1038/s41467-018-04422-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04422-2</ArticleId><ArticleId IdType="pmc">PMC5997668</ArticleId><ArticleId IdType="pubmed">29895861</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S.M., Youle R.J. PINK1- and Parkin-mediated mitophagy at a glance. J. Cell Sci. 2012;125:795&#x2013;799. doi: 10.1242/jcs.093849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.093849</ArticleId><ArticleId IdType="pmc">PMC3656616</ArticleId><ArticleId IdType="pubmed">22448035</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryde K.R., Smith H.L., Chau K.Y., Schapira A.H. PINK1 disables the anti-fission machinery to segregate damaged mitochondria for mitophagy. J. Cell Biol. 2016;213:163&#x2013;171. doi: 10.1083/jcb.201509003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201509003</ArticleId><ArticleId IdType="pmc">PMC5084273</ArticleId><ArticleId IdType="pubmed">27091447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C., Cleveland D.W. Rethinking ALS: The FUS about TDP-43. Cell. 2009;136:1001&#x2013;1004. doi: 10.1016/j.cell.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC3110083</ArticleId><ArticleId IdType="pubmed">19303844</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang H., Liu G., Jiang Y., Fu J., Zhang B., Song R., Wang W. Pathway analysis of two amyotrophic lateral sclerosis GWAS highlights shared genetic signals with Alzheimer&#x2019;s disease and Parkinson&#x2019;s disease. Mol. Neurobiol. 2015;51:361&#x2013;369. doi: 10.1007/s12035-014-8673-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8673-1</ArticleId><ArticleId IdType="pubmed">24647822</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W., van der Spek R.A.A., Bakker M.K., van Vugt J., Hop P.J., Zwamborn R.A.J., de Klein N., Westra H.J., Bakker O.B., Deelen P., et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 2021;53:1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Swerdlow R.H., Parks J.K., Cassarino D.S., Trimmer P.A., Miller S.W., Maguire D.J., Sheehan J.P., Maguire R.S., Pattee G., Juel V.C., et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp. Neurol. 1998;153:135&#x2013;142. doi: 10.1006/exnr.1998.6866.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1998.6866</ArticleId><ArticleId IdType="pubmed">9743575</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh T., Jiao Y., Ferrando L.M., Yablonska S., Li F., Horoszko E.C., Lacomis D., Friedlander R.M., Carlisle D.L. Neuronal mitochondrial dysfunction in sporadic amyotrophic lateral sclerosis is developmentally regulated. Sci. Rep. 2021;11:18916. doi: 10.1038/s41598-021-97928-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-97928-7</ArticleId><ArticleId IdType="pmc">PMC8460779</ArticleId><ArticleId IdType="pubmed">34556702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J., Xu Z. Massive Mitochondrial Degeneration in Motor Neurons Triggers the Onset of Amyotrophic Lateral Sclerosis in Mice Expressing a Mutant SOD1. J. Neurosci. 1998;18:3241&#x2013;3250. doi: 10.1523/JNEUROSCI.18-09-03241.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-09-03241.1998</ArticleId><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins C.M., Jung C., Xu Z. ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci. 2003;4:16. doi: 10.1186/1471-2202-4-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-4-16</ArticleId><ArticleId IdType="pmc">PMC169170</ArticleId><ArticleId IdType="pubmed">12864925</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedrini S., Sau D., Guareschi S., Bogush M., Brown R.H., Jr., Naniche N., Kia A., Trotti D., Pasinelli P. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum. Mol. 2010;19:2974&#x2013;2986. doi: 10.1093/hmg/ddq202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq202</ArticleId><ArticleId IdType="pmc">PMC2901139</ArticleId><ArticleId IdType="pubmed">20460269</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., Brown R.H., Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruman I.I., Pedersen W.A., Springer J.E., Mattson M.P. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp. Neurol. 1999;160:28&#x2013;39. doi: 10.1006/exnr.1999.7190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1999.7190</ArticleId><ArticleId IdType="pubmed">10630188</ArticleId></ArticleIdList></Reference><Reference><Citation>Carri M.T., Ferri A., Battistoni A., Famhy L., Gabbianelli R., Poccia F., Rotilio G. Expression of a Cu, Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett. 1997;414:365&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">9315720</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Cozzolino M., Crosio C., Nencini M., Casciati A., Gralla E.B., Rotilio G., Valentine J.S., Carri M.T. Familial ALS-superoxide dismutases associate with mitochondria and shift their redox potentials. Proc. Natl. Acad. Sci. USA. 2006;103:13860&#x2013;13865. doi: 10.1073/pnas.0605814103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0605814103</ArticleId><ArticleId IdType="pmc">PMC1557633</ArticleId><ArticleId IdType="pubmed">16945901</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai Y.L., Coady T.H., Lu L., Zheng D., Alland I., Tian B., Shneider N.A., Manley J.L. ALS/FTD-associated protein FUS induces mitochondrial dysfunction by preferentially sequestering respiratory chain complex mRNAs. Genes. Dev. 2020;34:785&#x2013;805. doi: 10.1101/gad.335836.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.335836.119</ArticleId><ArticleId IdType="pmc">PMC7263147</ArticleId><ArticleId IdType="pubmed">32381627</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoica R., Paillusson S., Gomez-Suaga P., Mitchell J.C., Lau D.H., Gray E.H., Sancho R.M., Vizcay-Barrena G., De Vos K.J., Shaw C.E., et al. ALS/FTD-associated FUS activates GSK-3beta to disrupt the VAPB-PTPIP51 interaction and ER-mitochondria associations. EMBO Rep. 2016;17:1326&#x2013;1342. doi: 10.15252/embr.201541726.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201541726</ArticleId><ArticleId IdType="pmc">PMC5007559</ArticleId><ArticleId IdType="pubmed">27418313</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng J., Wang P., Chen X., Cheng H., Liu J., Fushimi K., Zhu L., Wu J.Y. FUS interacts with ATP synthase beta subunit and induces mitochondrial unfolded protein response in cellular and animal models. Proc. Natl. Acad. Sci. USA. 2018;115:E9678&#x2013;E9686. doi: 10.1073/pnas.1806655115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1806655115</ArticleId><ArticleId IdType="pmc">PMC6187197</ArticleId><ArticleId IdType="pubmed">30249657</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov M., Brown R.H., Matson W., Smart R., Hayden D., O&#x2019;Donnell H., Flint Beal M., Cudkowicz M. Increased oxidative damage to DNA in ALS patients. Free Radic. Biol. Med. 2000;29:652&#x2013;658. doi: 10.1016/S0891-5849(00)00349-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(00)00349-X</ArticleId><ArticleId IdType="pubmed">11033417</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann F.R., Manfredi G., Mawrin C., Beal M.F., Schon E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002;80:616&#x2013;625. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Horie Y., Iwata M. Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 2007;114:633&#x2013;639. doi: 10.1007/s00401-007-0299-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-007-0299-1</ArticleId><ArticleId IdType="pubmed">17929040</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Warita H., Murakami T., Abe K., Iwata M. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 2004;107:461&#x2013;474. doi: 10.1007/s00401-004-0837-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0837-z</ArticleId><ArticleId IdType="pubmed">15029445</ArticleId></ArticleIdList></Reference><Reference><Citation>Vielhaber S., Winkler K., Kirches E., Kunz D., Buchner M., Feistner H., Elger C.E., Ludolph A.C., Riepe M.W., Kunz W.S. Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 1999;169:133&#x2013;139. doi: 10.1016/S0022-510X(99)00236-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00236-1</ArticleId><ArticleId IdType="pubmed">10540022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ro L.S., Lai S.L., Chen C.M., Chen S.T. Deleted 4977-bp mitochondrial DNA mutation is associated with sporadic amyotrophic lateral sclerosis: A hospital-based case-control study. Muscle Nerve. 2003;28:737&#x2013;743. doi: 10.1002/mus.10504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10504</ArticleId><ArticleId IdType="pubmed">14639589</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramzon Y.A., Fratta P., Traynor B.J., Chia R. The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2020;14:42. doi: 10.3389/fnins.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.B. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Bredesen D.E., Rao R.V., Mehlen P. Cell death in the nervous system. Nature. 2006;443:796&#x2013;802. doi: 10.1038/nature05293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05293</ArticleId><ArticleId IdType="pmc">PMC3970704</ArticleId><ArticleId IdType="pubmed">17051206</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi S., Abramov A.Y. Mechanism of oxidative stress in neurodegeneration. Oxid. Med. Cell Longev. 2012;2012:428010. doi: 10.1155/2012/428010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/428010</ArticleId><ArticleId IdType="pmc">PMC3362933</ArticleId><ArticleId IdType="pubmed">22685618</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzino G., Irrera N., Cucinotta M., Pallio G., Mannino F., Arcoraci V., Squadrito F., Altavilla D., Bitto A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell Longev. 2017;2017:8416763. doi: 10.1155/2017/8416763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8416763</ArticleId><ArticleId IdType="pmc">PMC5551541</ArticleId><ArticleId IdType="pubmed">28819546</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips N.R., Simpkins J.W., Roby R.K. Mitochondrial DNA deletions in Alzheimer&#x2019;s brains: A review. Alzheimer&#x2019;s Dement. 2014;10:393&#x2013;400. doi: 10.1016/j.jalz.2013.04.508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2013.04.508</ArticleId><ArticleId IdType="pmc">PMC3800237</ArticleId><ArticleId IdType="pubmed">23850329</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R.X., Correia S.C., Zhu X., Smith M.A., Moreira P.I., Castellani R.J., Nunomura A., Perry G. Mitochondrial DNA oxidative damage and repair in aging and Alzheimer&#x2019;s disease. Antioxid. Redox Signal. 2013;18:2444&#x2013;2457. doi: 10.1089/ars.2012.5039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.5039</ArticleId><ArticleId IdType="pmc">PMC3671662</ArticleId><ArticleId IdType="pubmed">23216311</ArticleId></ArticleIdList></Reference><Reference><Citation>Mijaljica D., Prescott M., Devenish R.J. Mitophagy and mitoptosis in disease processes. Methods Mol. Biol. 2010;648:93&#x2013;106. doi: 10.1007/978-1-60761-756-3_6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-60761-756-3_6</ArticleId><ArticleId IdType="pubmed">20700707</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang E.F. Mitophagy and NAD(+) inhibit Alzheimer disease. Autophagy. 2019;15:1112&#x2013;1114. doi: 10.1080/15548627.2019.1596497.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1596497</ArticleId><ArticleId IdType="pmc">PMC6526831</ArticleId><ArticleId IdType="pubmed">30922179</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang E.F., Hou Y., Lautrup S., Jensen M.B., Yang B., SenGupta T., Caponio D., Khezri R., Demarest T.G., Aman Y., et al. NAD(+) augmentation restores mitophagy and limits accelerated aging in Werner syndrome. Nat. Commun. 2019;10:5284. doi: 10.1038/s41467-019-13172-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13172-8</ArticleId><ArticleId IdType="pmc">PMC6872719</ArticleId><ArticleId IdType="pubmed">31754102</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang E.F., Hou Y., Palikaras K., Adriaanse B.A., Kerr J.S., Yang B., Lautrup S., Hasan-Olive M.M., Caponio D., Dan X., et al. Mitophagy inhibits amyloid-beta and tau pathology and reverses cognitive deficits in models of Alzheimer&#x2019;s disease. Nat. Neurosci. 2019;22:401&#x2013;412. doi: 10.1038/s41593-018-0332-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0332-9</ArticleId><ArticleId IdType="pmc">PMC6693625</ArticleId><ArticleId IdType="pubmed">30742114</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang E.F., Waltz T.B., Kassahun H., Lu Q., Kerr J.S., Morevati M., Fivenson E.M., Wollman B.N., Marosi K., Wilson M.A., et al. Tomatidine enhances lifespan and healthspan in C. elegans through mitophagy induction via the SKN-1/Nrf2 pathway. Sci. Rep. 2017;7:46208. doi: 10.1038/srep46208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep46208</ArticleId><ArticleId IdType="pmc">PMC5387417</ArticleId><ArticleId IdType="pubmed">28397803</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng D., Liu L., Zhu Y., Chen Q. Molecular signaling toward mitophagy and its physiological significance. Exp. Cell Res. 2013;319:1697&#x2013;1705. doi: 10.1016/j.yexcr.2013.03.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2013.03.034</ArticleId><ArticleId IdType="pubmed">23603281</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L., Tian J., Du H. Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2017;57:1071&#x2013;1086. doi: 10.3233/JAD-160702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160702</ArticleId><ArticleId IdType="pmc">PMC5605817</ArticleId><ArticleId IdType="pubmed">27662318</ArticleId></ArticleIdList></Reference><Reference><Citation>Magrane J., Sahawneh M.A., Przedborski S., Estevez A.G., Manfredi G. Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J. Neurosci. 2012;32:229&#x2013;242. doi: 10.1523/JNEUROSCI.1233-11.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1233-11.2012</ArticleId><ArticleId IdType="pmc">PMC3566782</ArticleId><ArticleId IdType="pubmed">22219285</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng Z.H., Cai Q. Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration. Nat. Rev. Neurosci. 2012;13:77&#x2013;93. doi: 10.1038/nrn3156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3156</ArticleId><ArticleId IdType="pmc">PMC4962561</ArticleId><ArticleId IdType="pubmed">22218207</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos M., Lauwers E., Verstreken P. Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front. Synaptic. Neurosci. 2010;2:139. doi: 10.3389/fnsyn.2010.00139.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsyn.2010.00139</ArticleId><ArticleId IdType="pmc">PMC3059669</ArticleId><ArticleId IdType="pubmed">21423525</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis C.H., Kim K.Y., Bushong E.A., Mills E.A., Boassa D., Shih T., Kinebuchi M., Phan S., Zhou Y., Bihlmeyer N.A., et al. Transcellular degradation of axonal mitochondria. Proc. Natl. Acad. Sci. USA. 2014;111:9633&#x2013;9638. doi: 10.1073/pnas.1404651111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1404651111</ArticleId><ArticleId IdType="pmc">PMC4084443</ArticleId><ArticleId IdType="pubmed">24979790</ArticleId></ArticleIdList></Reference><Reference><Citation>Uittenbogaard M., Chiaramello A. Mitochondrial biogenesis: A therapeutic target for neurodevelopmental disorders and neurodegenerative diseases. Curr. Pharm. Des. 2014;20:5574&#x2013;5593. doi: 10.2174/1381612820666140305224906.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612820666140305224906</ArticleId><ArticleId IdType="pmc">PMC4823001</ArticleId><ArticleId IdType="pubmed">24606804</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrero-Mendez A., Almeida A., Fernandez E., Maestre C., Moncada S., Bolanos J.P. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat. Cell. Biol. 2009;11:747&#x2013;752. doi: 10.1038/ncb1881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1881</ArticleId><ArticleId IdType="pubmed">19448625</ArticleId></ArticleIdList></Reference><Reference><Citation>Demetrius L.A., Simon D.K. An inverse-Warburg effect and the origin of Alzheimer&#x2019;s disease. Biogerontology. 2012;13:583&#x2013;594. doi: 10.1007/s10522-012-9403-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-012-9403-6</ArticleId><ArticleId IdType="pubmed">23086530</ArticleId></ArticleIdList></Reference><Reference><Citation>Belanger M., Allaman I., Magistretti P.J. Brain energy metabolism: Focus on astrocyte-neuron metabolic cooperation. Cell Metab. 2011;14:724&#x2013;738. doi: 10.1016/j.cmet.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.08.016</ArticleId><ArticleId IdType="pubmed">22152301</ArticleId></ArticleIdList></Reference><Reference><Citation>Demetrius L.A., Magistretti P.J., Pellerin L. Alzheimer&#x2019;s disease: The amyloid hypothesis and the Inverse Warburg effect. Front. Physiol. 2014;5:522. doi: 10.3389/fphys.2014.00522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00522</ArticleId><ArticleId IdType="pmc">PMC4294122</ArticleId><ArticleId IdType="pubmed">25642192</ArticleId></ArticleIdList></Reference><Reference><Citation>Demetrius L.A., Driver J. Alzheimer&#x2019;s as a metabolic disease. Biogerontology. 2013;14:641&#x2013;649. doi: 10.1007/s10522-013-9479-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-013-9479-7</ArticleId><ArticleId IdType="pubmed">24249045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu W., Jhamandas J.H. Role of astrocytic glycolytic metabolism in Alzheimer&#x2019;s disease pathogenesis. Biogerontology. 2014;15:579&#x2013;586. doi: 10.1007/s10522-014-9525-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-014-9525-0</ArticleId><ArticleId IdType="pubmed">25106114</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotegher N., Perocheau D., Ferrazza R., Massaro G., Bhosale G., Zambon F., Rahim A.A., Guella G., Waddington S.N., Szabadkai G., et al. Correction: Impaired cellular bioenergetics caused by GBA1 depletion sensitizes neurons to calcium overload. Cell Death Differ. 2020;27:2534. doi: 10.1038/s41418-020-0525-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-020-0525-0</ArticleId><ArticleId IdType="pmc">PMC7370217</ArticleId><ArticleId IdType="pubmed">32152554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan L., Zhou C., Jin E., Kucharavy A., Zhang Y., Wen Z., Florens L., Li R. Cytosolic proteostasis through importing of misfolded proteins into mitochondria. Nature. 2017;543:443&#x2013;446. doi: 10.1038/nature21695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21695</ArticleId><ArticleId IdType="pmc">PMC5793917</ArticleId><ArticleId IdType="pubmed">28241148</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui H., Diaz F., Garcia S., Moraes C.T. Cytochrome c oxidase deficiency in neurons decreases both oxidative stress and amyloid formation in a mouse model of Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2007;104:14163&#x2013;14168. doi: 10.1073/pnas.0705738104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705738104</ArticleId><ArticleId IdType="pmc">PMC1955773</ArticleId><ArticleId IdType="pubmed">17715058</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino M.W., Nargund A.M., Haynes C.M. Signaling the mitochondrial unfolded protein response. Biochim. Biophys. Acta. 2013;1833:410&#x2013;416. doi: 10.1016/j.bbamcr.2012.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2012.02.019</ArticleId><ArticleId IdType="pmc">PMC3393825</ArticleId><ArticleId IdType="pubmed">22445420</ArticleId></ArticleIdList></Reference><Reference><Citation>Shpilka T., Haynes C.M. The mitochondrial UPR: Mechanisms, physiological functions and implications in ageing. Nat. Rev. Mol. Cell Biol. 2018;19:109&#x2013;120. doi: 10.1038/nrm.2017.110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.110</ArticleId><ArticleId IdType="pubmed">29165426</ArticleId></ArticleIdList></Reference><Reference><Citation>Venereau E., Ceriotti C., Bianchi M.E. DAMPs from Cell Death to New Life. Front. Immunol. 2015;6:422. doi: 10.3389/fimmu.2015.00422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00422</ArticleId><ArticleId IdType="pmc">PMC4539554</ArticleId><ArticleId IdType="pubmed">26347745</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G.Y., Nunez G. Sterile inflammation: Sensing and reacting to damage. Nat. Rev. Immunol. 2010;10:826&#x2013;837. doi: 10.1038/nri2873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2873</ArticleId><ArticleId IdType="pmc">PMC3114424</ArticleId><ArticleId IdType="pubmed">21088683</ArticleId></ArticleIdList></Reference><Reference><Citation>Roh J.S., Sohn D.H. Damage-Associated Molecular Patterns in Inflammatory Diseases. Immune. Netw. 2018;18:e27. doi: 10.4110/in.2018.18.e27.</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2018.18.e27</ArticleId><ArticleId IdType="pmc">PMC6117512</ArticleId><ArticleId IdType="pubmed">30181915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Koppel S.J., Weidling I.W., Roy N., Ryan L.N., Stanford J.A., Swerdlow R.H. Extracellular Mitochondria and Mitochondrial Components Act as Damage-Associated Molecular Pattern Molecules in the Mouse Brain. J. Neuroimmune Pharmacol. 2016;11:622&#x2013;628. doi: 10.1007/s11481-016-9704-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-016-9704-7</ArticleId><ArticleId IdType="pmc">PMC5097888</ArticleId><ArticleId IdType="pubmed">27562848</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Weidling I.W., Ji Y., Swerdlow R.H. Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration. Front. Immunol. 2017;8:508. doi: 10.3389/fimmu.2017.00508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.00508</ArticleId><ArticleId IdType="pmc">PMC5405073</ArticleId><ArticleId IdType="pubmed">28491064</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Carl S.M., Weber S.G., Ramanujan S.A., Festoff B.W., Linseman D.A., Swerdlow R.H. Mitochondrial lysates induce inflammation and Alzheimer&#x2019;s disease-relevant changes in microglial and neuronal cells. J. Alzheimer&#x2019;s Dis. 2015;45:305&#x2013;318. doi: 10.3233/JAD-142334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-142334</ArticleId><ArticleId IdType="pmc">PMC4605548</ArticleId><ArticleId IdType="pubmed">25537010</ArticleId></ArticleIdList></Reference><Reference><Citation>Picca A., Calvani R., Coelho-Junior H.J., Marzetti E. Cell Death and Inflammation: The Role of Mitochondria in Health and Disease. Cells. 2021;10:537. doi: 10.3390/cells10030537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10030537</ArticleId><ArticleId IdType="pmc">PMC7998762</ArticleId><ArticleId IdType="pubmed">33802550</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Swerdlow R.H. Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer&#x2019;s Disease. Curr. Top. Med. Chem. 2016;16:849&#x2013;857. doi: 10.2174/1568026615666150827095102.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1568026615666150827095102</ArticleId><ArticleId IdType="pmc">PMC5480219</ArticleId><ArticleId IdType="pubmed">26311426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>